JP2019534286A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534286A5
JP2019534286A5 JP2019522672A JP2019522672A JP2019534286A5 JP 2019534286 A5 JP2019534286 A5 JP 2019534286A5 JP 2019522672 A JP2019522672 A JP 2019522672A JP 2019522672 A JP2019522672 A JP 2019522672A JP 2019534286 A5 JP2019534286 A5 JP 2019534286A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
date
document
bbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019522672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019534286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/058267 external-priority patent/WO2018081254A1/en
Publication of JP2019534286A publication Critical patent/JP2019534286A/ja
Publication of JP2019534286A5 publication Critical patent/JP2019534286A5/ja
Pending legal-status Critical Current

Links

JP2019522672A 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性有色ペプチド Pending JP2019534286A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662412938P 2016-10-26 2016-10-26
US62/412,938 2016-10-26
PCT/US2017/058267 WO2018081254A1 (en) 2016-10-26 2017-10-25 Cancer binding chromatic peptides that are targeted for disintegration by radiant energy

Publications (2)

Publication Number Publication Date
JP2019534286A JP2019534286A (ja) 2019-11-28
JP2019534286A5 true JP2019534286A5 (enExample) 2020-10-08

Family

ID=62025444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019522672A Pending JP2019534286A (ja) 2016-10-26 2017-10-25 放射エネルギーによる崩壊の標的とされる癌結合性有色ペプチド

Country Status (4)

Country Link
US (1) US20190275173A1 (enExample)
JP (1) JP2019534286A (enExample)
CN (1) CN109963874A (enExample)
WO (1) WO2018081254A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111484442B (zh) 2018-06-01 2021-11-09 杭州阿诺生物医药科技有限公司 一种具有抗肿瘤活性的csf1r抑制剂中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080058785A1 (en) * 2006-04-12 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US20100183504A1 (en) * 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
US8524239B2 (en) * 2010-07-09 2013-09-03 The United States of America as represented by the Secrectary, Department of Health and Human Services Photosensitizing antibody-fluorophore conjugates
JP6192799B2 (ja) * 2013-03-15 2017-09-06 パーデュー・リサーチ・ファウンデーションPurdue Research Foundation 腫瘍の標的画像化に使用される化合物にコンジュゲートしているアミノ酸連結基の合成および組成物

Similar Documents

Publication Publication Date Title
JP2019502892A5 (enExample)
JP2013517798A5 (enExample)
JP2012074699A5 (enExample)
JP2016153424A5 (enExample)
JP2012504317A5 (enExample)
EA201070127A1 (ru) Способы лечения легочной гипертензии, родственных заболеваний и нарушений и композиции для их осуществления
JP2016523701A5 (enExample)
JP2019516789A5 (enExample)
JP2016510582A5 (enExample)
JP2019514354A5 (enExample)
JP2016516303A5 (enExample)
JP2020512939A5 (enExample)
JP2020500643A5 (enExample)
JP2019534286A5 (enExample)
JP2019527311A5 (enExample)
JP2020505322A5 (enExample)
JP2014532453A5 (enExample)
JP2019534285A5 (enExample)
EP4081517A4 (en) CRYSTALLINE FORMS OF (S)-1-(1-ACRYLOYLPYRROLIDINE-3-YL)-3-((3,5-DIMETHOXYPHENYL)ETHINYL)-5-(METHYLAMINO)-1H-PYRAZOLE-4-CARBOXAMIDE
JP2013518354A5 (enExample)
JP2019536015A5 (enExample)
RU2021109614A (ru) N-бензоилгидразоны камфоры, используемые в качестве ингибиторов репликации ортопоксвирусов
CN302535220S (zh) 录音笔(hq-90)
CN302061246S (zh) 门夹(2745)
CN302111393S (zh) 订书机(5003)